ReShape Lifesciences Inc. (RSLS)
0.38
-0.02 (-3.85%)
At close: Apr 15, 2025, 3:59 PM
0.38
-1.27%
After-hours: Apr 15, 2025, 07:59 PM EDT
-3.85% (1D)
| Bid | 0.37 |
| Market Cap | 3.26M |
| Revenue (ttm) | 8.01M |
| Net Income (ttm) | -7.13M |
| EPS (ttm) | -13.83 |
| PE Ratio (ttm) | -0.03 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.38 |
| Volume | 1,713,467 |
| Avg. Volume (20D) | 12,992,204 |
| Open | 0.39 |
| Previous Close | 0.40 |
| Day's Range | 0.37 - 0.39 |
| 52-Week Range | 0.30 - 29.00 |
| Beta | 1.93 |
About RSLS
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investi...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 6, 2016
Employees 17
Stock Exchange NASDAQ
Ticker Symbol RSLS
5 days ago
-9.71%
ReShape Lifesciences shares are trading higher aft...
Unlock content with
Pro Subscription
1 week ago
-9.71%
ReShape Lifesciences shares are trading lower on possible continued weakness after the company reported a year-over-year decrease in FY24 revenue results on Monday.
